---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-067231"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:13:12.464464+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sera Prognostics appoints Lee Anderson as Chief Commercial Officer; 30-year diagnostics veteran to lead PreTRM rollout

## Summary
- Lee Anderson appointed CCO effective May 8, 2025; reports to CEO Zhenya Lindgardt.
- Anderson previously led US Oncology Sales at Genomic Health (acquired by Exact Sciences) and was CCO at Biofidelity.
- He will drive commercial adoption of the PreTRM test following positive PRIME study results.
- Company is in commercial phase; Anderson brings over 30 years of healthcare sales and marketing leadership.

## SEC filing metadata
- accession: 0000950170-25-067231
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000095017025067231/0000950170-25-067231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000095017025067231/sera-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-067231
- JSON: https://secwatch.observer/filing/0000950170-25-067231.json
- Plain text: https://secwatch.observer/filing/0000950170-25-067231.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.